Wikyungtang inhibits proliferation of A549 human lung cancer cells via inducing apoptosis and suppressing cyclooxygenase-2 activity

Oncology Reports

Volumn 11, Issue 4, 2004, Pages 853-856

  Park, Dong Il ^a   Choi, Hae Yun ^a   Kam, Chul Woo ^a   Park, Cheol ^a,b   Choi, Tae Hyun ^c   Lee, Won Ho ^b   Choi, Yung Hyun ^a  

^a Dong Eui University   (South Korea)

^b Pusan National University   (South Korea)

^c Taegu Technical College   (South Korea)

Author keywords

Apoptosis; Caspase; Cyclooxygenase 2; Wikyungtang

Indexed keywords

ACTIN; ANTINEOPLASTIC AGENT; CASP3 PROTEIN, HUMAN; CASP9 PROTEIN, HUMAN; CASPASE; CASPASE 3; CASPASE 9; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INHIBITOR OF APOPTOSIS PROTEIN; ISOENZYME; MEMBRANE PROTEIN; PHOSPHOLIPASE C; PHOSPHOLIPASE C GAMMA; PLANT EXTRACT; PROSTAGLANDIN SYNTHASE; PROTEIN; PROTEIN BCL 2; PTGS1 PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN; WIKYUNGTANG;

APOPTOSIS; ARTICLE; CARCINOMA; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HUMAN; LUNG TUMOR; MEDICINAL PLANT; METABOLISM; PATHOLOGY; PHYTOTHERAPY; TUMOR CELL LINE;

ACTINS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA; CASPASE 3; CASPASE 9; CASPASES; CELL LINE, TUMOR; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; ISOENZYMES; LUNG NEOPLASMS; MEMBRANE PROTEINS; PHOSPHOLIPASE C; PHOSPHOLIPASE C GAMMA; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 16544390621     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.4.853     Document Type: Article

References (21)

1. Evans VG: Multiple pathways to apoptosis. Cell Biol Int 17: 461-476, 1993.
2. Stennicke HR and Salvesen GS: Properties of the caspases. Biochim Biophys Acta 1387: 17-31, 1998. (Pubitemid 28529204)
3. Ekert PG, Silke J and Vaux DL: Caspase inhibitors. Cell Death Differ 6: 1081-1086, 1999.
4. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG and Earnshaw WC: Cleavage of poly(ADP-ribose polymerase by a proteinase with properties like ICE. Nature 371: 346-347, 1994. (Pubitemid 24300618)
5. Rosse T, Olivier R, Monney L, Rager M, Conus S, Fellay I, Jansen B and Borner C: Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 391: 496-499, 1998. (Pubitemid 28086551)
6. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B and Reed JC: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805, 1994. (Pubitemid 24163411)
7. Roy N, Deveraux QL, Takahashi R, Salvesen GS and Reed JC: The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 16: 6914-6925, 1997. (Pubitemid 27520792)
8. Deveraux QL and Reed JC: IAP family proteins-suppressors of apoptosis. Genes Dev 13: 239-252, 1999.
9. Han Z, Li G, Bremner TA, Lange TS, Zhang G, Jemmerson R, Wyche JH and Hendrickson EA: A cytosolic factor is required for mitochondrial cytochrome c efflux during apoptosis. Cell Death Differ 5: 469-479, 1998. (Pubitemid 28356565)
10. Soh JW and Weinstein IB: Role of COX-independent targets of NSAIDs and related compounds in cancer prevention and treatment. Prog Exp Tumor Res 37: 261-285, 2003.
11. Anderson WF, Umar A, Viner JL and Hawk ET: The role of cyclooxygenase inhibitors in cancer prevention. Curr Pharm Des 8: 1035-1062, 2002. (Pubitemid 34498634)
12. Smith WL, Garavito RM and DeWitt DL: Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271: 33157-33160, 1996. (Pubitemid 27010118)
13. Tao X, Schulze-Koops H, Ma L, Cai J, Mao Y and Lipsky PE: Effects of Tripterygium wilfordii hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 production. Arthritis Rheum 41: 130-138, 1998. (Pubitemid 28041931)
14. Repovic P, Mi K and Benveniste EN: Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1beta, tumor necrosis factor-alpha, and bacterial lipopolysaccharide. Glia 42: 433-446, 2003. (Pubitemid 36702284)
15. Cao Y and Prescott SM: Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. J Cell Physiol 190: 279-286, 2002. (Pubitemid 34111968)
16. Crofford LJ: COX-1 and COX-2 tissue expression: implications and predictions. J Rheumatol 49 (Suppl): 15-19, 1997.
17. Choi YH, Lee SJ, Nguyen P, Jang JS, Lee J, Wu ML, Takano E, Maki M, Henkart PA and Trepel JB: Regulation of cyclin D1 by calpain protease. J Biol Chem 272: 28479-28484, 1997. (Pubitemid 27517796)
18. Bae SS, Perry DK, Oh YS, Choi JH, Galadari SH, Ghayur T, Ryu SH, Hannun YA and Suh PG: Proteolytic cleavage of phospholipase C-gamma1 during apoptosis in Molt-4 cells. FASEB J 14: 1083-1092, 2000. (Pubitemid 30350389)
19. Gately S and Kerbel R: Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis. Prog Exp Tumor Res 37: 179-192, 2003. (Pubitemid 36767986)
20. Dempke W, Rie C, Grothey A and Schmoll HJ: Cyclooxygenase-2: a novel target for cancer chemotherapy? J Cancer Res Clin Oncol 127: 411-417, 2001. (Pubitemid 32524357)
21. Smith WL, DeWitt DL and Garavito RM: Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69: 145-182, 2000.